4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-22-029810
Options or other derivatives
- Director acquired 0 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pershing Edward · Director
Table II: Derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-23 | Grant or award : show line 1 in the form 8% Unsecured Convertible Promissory Note due 2023 | +0 | $75,000.00 | $0 | D | |
| 2022-09-30 | Grant or award : show line 2 in the form 8% Unsecured Convertible Promissory Note due 2023 | +0 | $110,000.00 | $0 | D | |
| 2022-10-14 | Grant or award : show line 3 in the form 8% Unsecured Convertible Promissory Note due 2023 | +0 | $50,000.00 | $0 | D | |
| 2022-10-27 | Grant or award : show line 4 in the form 8% Unsecured Convertible Promissory Note due 2023 | +0 | $7,500.00 | $0 | D |
Loading xslF345X03/ownership.xml…